2023-09-11 16:42:57 ET
More on Geron
- Seeking Alpha’s Quant Rating on Geron
- Historical earnings data for Geron
- Financial information for Geron
- FDA's Twist In Geron's Telomerase Tale (Rating Downgrade)
- Geron Stock: These Prices Are Unlikely To Return
- Wedbush adds Geron to Best Ideas List, joining Ascendis, MoonLake
- Geron blood cancer therapy accepted for FDA standard review
- Geron gains after submitting marketing application for blood cancer therapy
For further details see:
Geron announces retirement of CFO Olivia Bloom; appoints Michelle Robertson as new CFO